Evaluation of Increased Fruits and Vegetables Consumption in Chronic Kidney Disease
1 other identifier
interventional
13
1 country
1
Brief Summary
This study aims to investigate the feasibility of increasing dietary consumption of a rich variety of fruits and vegetables (including those that are potassim-rich) in patients with chronic kidney disease through use of nutritional counselling and hyperkalemia management with patiromer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 24, 2020
CompletedFirst Submitted
Initial submission to the registry
April 28, 2021
CompletedFirst Posted
Study publicly available on registry
September 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
August 2, 2024
July 1, 2024
6 years
April 28, 2021
July 31, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
By increasing the consumption of Fruits and Vegetable in their daily diet using the Nutritional Fruits and Vegetable Diary based off of the USDA Nutritive Value of foods and completing the Quality of Life Nutritional Questionnaire.
Participants will increase the Fruit and vegetable consumption by following a Diet plan listed in the Nutritional Diary provided to them by the study site in the beginning of the study while taking Patiromer (Veltassa). This will record their daily intake of 26-28 servings of fruit and vegetables weekly. The Nutritional diary lists a Diet Plan that measures the serving size of 26-28 servings of the fruits and vegetables. The measurement of fruits and vegetables has been calculated by the Nutritionist based off of the USDA Nutritive Value of foods and listed on the diary to explain the serving sizes and suggestions of meal plans.
3 years
Secondary Outcomes (1)
The Kidney Function levels will be tested at each visit from blood samples provided by the subject.
3 years
Other Outcomes (4)
Measure the subjects diet intake related to Quality of Life
3 years
Measure the description of Daily bowel moments to test for constipation
3 years
Urine will be measured to evaluate kidney function in subjects with Chronic kidney disease
3 years
- +1 more other outcomes
Study Arms (1)
chronic kidney disease patients
OTHEREvaluation of Increased fruits and vegetables consumption in chronic kidney disease patients maintaining normokalemia with patiromer
Interventions
Increase fruits and vegetable consumption in chronic Kidney Patients to maintain Normokalemia
Eligibility Criteria
You may qualify if:
- Adult patients ≥ 18 years of age with chronic kidney disease and hyperkalemia
- Chronic kidney disease is defined as eGFR 15-44ml/min/1.73m2
- Documented hyperkalemia which is defined as serum potassium ≥ 5.0 mmol/L during the last 90 days
- Diet evaluation for hyperkalemia (serum potassium ≥ 5.0) during the last 90 days
- Patients receiving RASS inhibitors, beta-blockers, or diuretics to be on stable doses for 2 weeks
- Patients already receiving patiromer are eligible
You may not qualify if:
- Patients with a known allergy to patiromer
- Patients currently taking other potassium controlling agents.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nand Wadhwalead
Study Sites (1)
NY Health
Port Jefferson Station, New York, 11776, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nand Wadwha, MD
NY Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Nephrologist, Principal Investigator
Study Record Dates
First Submitted
April 28, 2021
First Posted
September 20, 2021
Study Start
November 24, 2020
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
August 2, 2024
Record last verified: 2024-07